Anti-tumor necrosis factor α: originators versus biosimilars, comparison in clinical response assessment in a multicenter cohort of patients with inflammatory arthropathies. (2023). Reumatismo, 75(4). https://doi.org/10.4081/reumatismo.2023.1602